Yale scientists develop an injection-based therapy for skin cancer
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.
The results are published in the
Proceedings of the National Academy of Sciences.
For a lot of patients, treating skin cancer is much more involved than it would be if there was a way to effectively treat them with a simple procedure like an injection. That s always been a holy grail in dermatology to find a simpler way to treat skin cancers such as basal cell carcinoma and squamous cell carcinoma.
By William Weir
February 1, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
Bioadhesive nanoparticles (white) after being taken up by skin cancer tumor cells during in vitro culture. (Image credit: Julia Lewis)
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.
“For a lot of patients, treating skin cancer is much more involved than it would be if there was a way to effectively treat them with a simple procedure like an injection,” said Dr. Michael Girardi, professor and vice chair of dermatology at Yale School of Medicine and senior author of the study. “That’s always been a holy grail in dermatology to find a simpler way to treat skin cancers such as basal cell carcinoma and squamous cell carcinoma.”